Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.

12 Issues per year


IMPACT FACTOR 2017: 3.556

CiteScore 2017: 2.34

SCImago Journal Rank (SJR) 2017: 1.114
Source Normalized Impact per Paper (SNIP) 2017: 1.188

Online
ISSN
1437-4331
See all formats and pricing
More options …
Volume 48, Issue 10

Issues

Clinical significance of serum macrophage-colony stimulating factor (M-CSF) in esophageal cancer patients and its comparison with classical tumor markers

Marta Łukaszewicz-Zając / Barbara Mroczko / Mirosław Kozłowski / Jacek Nikliński / Jerzy Laudański / Maciej Szmitkowski
Published Online: 2010-07-07 | DOI: https://doi.org/10.1515/CCLM.2010.274

Abstract

Background: Hematopoietic growth factors (HGFs), such as macrophage-colony stimulating factor (M-CSF) are produced aberrantly in many malignancies. Esophageal cancer (EC) is characterized by late diagnosis, rapid progression and poor survival. The purpose of the present study was to determine the clinical usefulness of M-CSF in the diagnosis of EC and its histological type – squamous cell cancer of the esophagus (ESCC).

Methods: The study included 80 patients with EC (54 with ESCC and 26 with adenocarcinoma of the esophagus) and 30 healthy subjects. The serum concentrations of M-CSF, carcinoembryonic antigen (CEA) and squamous cell cancer antigen (SCC-Ag) were determined using immunoenzyme assays. We defined the percentage of increased concentrations of proteins tested and the areas under the receiver-operating characteristics (ROC) curves.

Results: In EC and ESCC patients, serum concentrations of M-CSF, CEA and SCC-Ag were significantly higher compared with healthy subjects. Concentrations of M-CSF in both groups analyzed (EC and ESCC) showed a tendency for increases with depth of tumor invasion, the presence of lymph node and distant metastases. The combined use of M-CSF with SCC-Ag increased their percentage of increased concentrations, and this value was higher than for classical tumor markers in both groups analyzed. The area under ROC curve for M-CSF was larger than for CEA in EC patients.

Conclusions: Our findings suggest the potential usefulness of serum M-CSF concentrations as a tumor marker for EC, especially in combination with SCC-Ag. However, the diagnostic value of this cytokine may be limited because of its non-specific nature.

Clin Chem Lab Med 2010;48:1467–73.

Keywords: esophageal cancer; M-CSF; tumor markers

About the article

Corresponding author: Professor Maciej Szmitkowski, Department of Biochemical Diagnostics, Medical University, Białystok, Waszyngtona 15 a, 15-269 Białystok, Poland Phone: +48-85-7468785, Fax: +48-85-7468585,


Received: 2009-12-03

Accepted: 2010-04-21

Published Online: 2010-07-07

Published in Print: 2010-10-01


Citation Information: Clinical Chemistry and Laboratory Medicine, Volume 48, Issue 10, Pages 1467–1473, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/CCLM.2010.274.

Export Citation

©2010 by Walter de Gruyter Berlin New York.Get Permission

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
George Vasiliades, Nikolaos Kopanakis, Michalis Vasiloglou, George Zografos, Helias Margaris, Kyriaki Masselou, Evniki Kokosi, and Theodore Liakakos
The International Journal of Biological Markers, 2012, Volume 27, Number 3, Page 186
[2]
RU ZHOU, YIMING ZHOU, and ZONGYOU CHEN
Biomedical Reports, 2013, Volume 1, Number 6, Page 845
[3]
Marta Łukaszewicz-Zając, Barbara Mroczko, Mirosław Kozłowski, and Maciej Szmitkowski
Disease Markers, 2016, Volume 2016, Page 1
[4]
Liu Yang, Qian Wu, Le Xu, Weijuan Zhang, Yu Zhu, Haiou Liu, Jiejie Xu, and Jianxin Gu
BMC Cancer, 2015, Volume 15, Number 1
[5]
Rodrigo Nalio Ramos, Cristiano Jacob de Moraes, Bruna Zelante, and José Alexandre M. Barbuto
Clinical and Developmental Immunology, 2013, Volume 2013, Page 1
[6]
M. Łukaszewicz-Zając, B. Mroczko, M. Kozłowski, J. Nikliński, J. Laudański, and M. Szmitkowski
Diseases of the Esophagus, 2012, Volume 25, Number 3, Page 242
[7]
Marta Łukaszewicz-Zając, Barbara Mroczko, Mirosław Kozłowski, Jacek Nikliński, Jerzy Laudański, Maria Siewko, and Maciej Szmitkowski
Journal of Clinical Laboratory Analysis, 2012, Volume 26, Number 2, Page 73

Comments (0)

Please log in or register to comment.
Log in